CytoMed Therapeutics Limited — Cash Flow (NASDAQ:GDTC) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities -1.04 M-2.6 M-1.98 M — Cash from investing activities -353.11 K-2.14 M824.58 K — Cash from financing activities 722.71 K8.28 M-47.5 K — Free cash flow -1.04 M-2.6 M-1.98 M —

Notícias

Ações da CytoMed sobem após anúncio de parceria para ensaio clínico na Malásia

CytoMed stock jumps after announcing clinical trial partnership in Malaysia

CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital

CytoMed Therapeutics garante investimento de US$ 500.000 para subsidiária

CytoMed Therapeutics secures $500,000 investment for subsidiary

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

CytoMed apresenta resultados pré-clínicos promissores para tratamento de leucemia

CytoMed reports promising preclinical results for leukemia treatment

CytoMed Therapeutics shareholders approve all proposals at annual meeting

CytoMed Therapeutics schedules annual shareholder meeting